CoreAge Rx vs Fitish
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Fitish head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
Fitish
FDA warning letter, June 2026 — issued to FITISH. See the FDA's warning letter database.
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 75 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Fitish a bad call — it's best for people who want portal-based compounded glp-1 care and will confirm prescription-specific billing and refund terms. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Fitish |
|---|---|---|
| Brief Score | 94/100 (A) | 75/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Confirm current price Earlier listing: $219/mo compounded semaglutide; current product quote could not be reconfirmed. Full price detailsCompounded semaglutide offered. Current medication quote unknown; earlier observed $219/mo compounded; current semaglutide product page was unavailable during review |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | $339 per monthly supply Compounded tirzepatide; consultation, medication if approved and shipping advertised as included. Full price details$339 for a monthly supply of compounded tirzepatide; advertised consult, medication if approved and shipping included |
| Coverage | US only; restrictions by state, confirmed at intake | Confirm current prescription-specific state access; no complete coverage list verified |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Fitish: Tirzepatide is advertised at $339 per monthly supply with consultation and shipping. Current semaglutide quote is unconfirmed. Clarify refund, renewal and pharmacy details.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.